Pulse Biosciences Names van den Broek to Board of Directors
7 August 2020 - - US-based novel bioelectric medicine company Pulse Biosciences, Inc. (NASDAQ: PLSE) has appointed Richard van den Broek to its board of directors, the company said.

In connection with his appointment to the board, van den Broek will also serve as a member of the audit committee and the compensation committee of the board.

van den Broek currently serves as managing partner of HSMR Advisors, LLC, a position he has held since February 2004, and as a director of PhaseBio Pharmaceuticals, Inc. since February 2019.

He previously served on the boards of directors of Pharmacyclics, Inc. from December 2009 to April 2015, Response Genetics, Inc. from December 2010 to September 2015, Special Diversified Opportunities, Inc. from March 2008 to October 2015 and Celldex Therapeutics, Inc. from December 2014 to December 2016.

van den Broek received an A.B. from Harvard University and is a Chartered Financial Analyst.

Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve and extend the lives of patients.

If cleared, the CellFX System will be the first commercial product to harness the distinctive advantages of the company's proprietary Nano-Pulse Stimulation technology to treat a variety of applications for which an optimal solution remains unfulfilled.

Nano-Pulse Stimulation technology delivers nano-second pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue.

Subject to regulatory approval, the initial commercial use of the CellFX System is expected to address a range of dermatologic conditions that share high demand among patients and practitioners for improved and durable aesthetic outcomes.

Designed as a multi-application platform, the CellFX System is intended to offer customer value with a utilization-based revenue model across an expanding spectrum of clinical applications.

Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.